Seismic Therapeutic has dosed the first healthy participant cohort in the randomised Phase I trial of bifunctional antibody S ...

J&J has reported data from the Phase III ICONIC-LEAD trial’s subgroup analysis evaluating icotrokinra in treating plaque ...

AI tools are faster at drafting clinical trial documents, but human writers remain indispensable for logical reasoning.

Oculis has concluded subject enrolment for the Phase III clinical trials of OCS-01 eye drops for diabetic macular oedema.

Amylyx Pharmaceuticals has dosed the first subject in the Phase I LUMINA trial, investigating AMX0114, a potential treatment ...

Worldwide Clinical Trials (Worldwide) has introduced a new AI-driven tool for improving optimisation of studies.

In 2023, a report by Lord James O’Shaughnessy found the UK had dropped from fourth to tenth as global contributors to ...

At AAN 2025, three posters presented the sustained long-term efficacy and real-world impact of Lundbeck’s Vyepti for migraine ...

One in three women will become pregnant after an MS diagnosis, therefore consideration of the maternal-infant dyad is needed.

Oral triptans are considered the industry gold standard acute treatments and there are currently seven approved, all with ...

Sarepta and Roche announced a 16-year-old US patient dosed with Elevidys died of acute liver failure in March 2025.

Three companies recently announced progression in their clinical research for next-generation Covid-19 vaccines: INOVIO, ...